Tigermed reports share capital and issued share update

Hangzhou Tigermed Consulting (SZSE:300347) has released its monthly report on securities changes, reporting the status of its share capital and issued shares as of March 31, 2025. The company's registered share capital remains consistent, with A shares at RMB741,823,770 and H shares at RMB123,124,800, totaling RMB864,948,570. The number of issued A shares (excluding treasury shares) stands at 732,017,470 with 9,806,300 treasury shares, resulting in 741,823,770 shares outstanding. The number of H shares (excluding treasury shares) is 123,124,800, with zero treasury shares, resulting in 123,124,800 shares outstanding. The company also noted previous share repurchases between May 2024 and February 2025, with the repurchased shares held as treasury stock.